We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$189M
AUM Growth
+$13.3M
Cap. Flow
-$3.27M
Cap. Flow %
-1.73%
Top 10 Hldgs %
24.14%
Holding
169
New
20
Increased
29
Reduced
82
Closed
14

Top Buys

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$3M
2
APD icon
Air Products & Chemicals
APD
+$2.21M
3
ORCL icon
Oracle
ORCL
+$1.67M
4
TER icon
Teradyne
TER
+$1.12M
5
PH icon
Parker-Hannifin
PH
+$953K

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.82M
2
AMZN icon
Amazon
AMZN
+$1.48M
3
AVGO icon
Broadcom
AVGO
+$1.19M
4
AMGN icon
Amgen
AMGN
+$1.13M
5
SBUX icon
Starbucks
SBUX
+$1.01M

Sector Composition

Rank Sector Weight
1 Industrials 21.74%
2 Healthcare 18.33%
3 Technology 16.98%
4 Consumer Staples 11.96%
5 Consumer Discretionary 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAT icon
76
Applied Materials
AMAT
$334B
$896K 0.47%
5,530
+2,405
+77% +$353K
ELV icon
77
Elevance Health
ELV
$90.6B
$896K 0.47%
1,900
-35
-2% -$16.2K
LRCX icon
78
Lam Research
LRCX
$339B
$862K 0.46%
11,000
+5,750
+110% +$392K
CSCO icon
79
Cisco
CSCO
$434B
$844K 0.45%
16,714
-13,910
-45% -$711K
LMT icon
80
Lockheed Martin
LMT
$123B
$818K 0.43%
1,804
+250
+16% +$111K
GSK icon
81
GSK
GSK
$100B
$802K 0.42%
21,630
– –
MRVL icon
82
Marvell Technology
MRVL
$199B
$783K 0.41%
12,975
-1,890
-13% -$102K
MCHP icon
83
Microchip Technology
MCHP
$38.8B
$780K 0.41%
8,650
+3,575
+70% +$291K
ABBV icon
84
AbbVie
ABBV
$465B
$779K 0.41%
5,027
-573
-10% -$83.5K
WDAY icon
85
Workday
WDAY
$46B
$772K 0.41%
+2,795
New +$665K
GIS icon
86
General Mills
GIS
$19.6B
$725K 0.38%
11,125
-8,300
-43% -$536K
MAS icon
87
Masco
MAS
$13.6B
$700K 0.37%
10,450
+3,175
+44% +$184K
ROL icon
88
Rollins
ROL
$16.2B
$673K 0.36%
15,400
-5,800
-27% -$226K
FTNT icon
89
Fortinet
FTNT
$126B
$672K 0.36%
11,475
+6,150
+115% +$340K
SBUX icon
90
Starbucks
SBUX
$110B
$664K 0.35%
6,920
-10,375
-60% -$1.01M
CL icon
91
Colgate-Palmolive
CL
$69.4B
$661K 0.35%
8,288
– –
PYPL icon
92
PayPal
PYPL
$46B
$654K 0.35%
10,655
-920
-8% -$52.7K
BA icon
93
Boeing
BA
$166B
$652K 0.35%
2,503
-25
-1% -$5.35K
CVX icon
94
Chevron
CVX
$427B
$634K 0.34%
4,250
-2,500
-37% -$378K
VZ icon
95
Verizon
VZ
$214B
$623K 0.33%
16,524
-425
-3% -$15K
PATK icon
96
Patrick Industries
PATK
$2.27B
$620K 0.33%
9,263
-412
-4% -$22.6K
GXO icon
97
GXO Logistics
GXO
$5.34B
$583K 0.31%
9,525
-25
-0.3% -$1.4K
LYV icon
98
Live Nation Entertainment
LYV
$39.7B
$583K 0.31%
6,225
– –
SONY icon
99
Sony
SONY
$140B
$563K 0.3%
29,750
– –
TDG icon
100
TransDigm Group
TDG
$60B
$561K 0.3%
555
-90
-14% -$83K
2 3
4
5 6

Similar funds

GFP
Guardian Financial Partners Orange, California $257M AUM 19.03% 1-Year Est. Return
UI
Untitled Investments New York $257M AUM 15.31% 1-Year Est. Return
HWA
HMV Wealth Advisors Shreveport, Louisiana $257M AUM 26.62% 1-Year Est. Return
LGW
Leslie Global Wealth Itasca, Illinois $257M AUM 23.12% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $257M AUM 25.68% 1-Year Est. Return
6F
626 Financial Portage, Michigan $257M AUM 22.23% 1-Year Est. Return
MCP
Miller Capital Partners Troy, Michigan $257M AUM
BWM
Birchcreek Wealth Management Miami Township, Ohio $257M AUM 34.72% 1-Year Est. Return

New England Research & Management's Q4 2023 Portfolio in Review

As of Q4 2023, New England Research & Management held 169 positions worth $189M, up 7.6% from $175M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q4 2023 filing shows 20 new, 29 increased, 82 reduced and 14 closed positions. Its largest new stake was Jacobs Solutions: 27,534 shares worth $2.96M. The largest sale was UnitedHealth, an estimated $1.82M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • New England Research & Management's largest Q4 2023 buy was Jacobs Solutions: 27,534 shares worth $2.96M.
  • New England Research & Management added most to Oracle in Q4 2023, an estimated $1.67M increase.
  • New England Research & Management's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $1.82M.
  • New England Research & Management fully exited Broadcom in Q4 2023, selling an estimated $1.19M.
  • New England Research & Management's ten largest holdings make up 24% of its $189M portfolio in Q4 2023.
  • New England Research & Management opened 20 new positions and closed 14 in Q4 2023.
  • New England Research & Management's portfolio value rose 7.6% quarter-over-quarter to $189M.

Based on New England Research & Management's 13F filing for Q4 2023, filed 6 Feb 2024.